These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26839355)

  • 41. Hemorrhagic transformation is related to the duration of occlusion and treatment with tissue plasminogen activator in a nonembolic stroke model.
    Fagan SC; Nagaraja TN; Fenstermacher JD; Zheng J; Johnson M; Knight RA
    Neurol Res; 2003 Jun; 25(4):377-82. PubMed ID: 12870264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endogenous tissue plasminogen activator increases hemorrhagic transformation induced by heparin after ischemia reperfusion in rat brains.
    Tang J; Li YJ; Li Q; Mu J; Yang DY; Xie P
    Neurol Res; 2010 Jun; 32(5):541-6. PubMed ID: 19309545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperglycemia accentuates persistent "functional uncoupling" of cerebral microvascular nitric oxide and superoxide following focal ischemia/reperfusion in rats.
    Fabian RH; Kent TA
    Transl Stroke Res; 2012 Dec; 3(4):482-90. PubMed ID: 24323834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemorrhagic transformation during thrombolytic therapy and reperfusion: effects of age, blood pressure, and matrix metalloproteinases.
    Lyden PD
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):532-8. PubMed ID: 23453556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperbaric oxygen preconditioning attenuates hemorrhagic transformation through increasing PPARγ in hyperglycemic MCAO rats.
    Bian H; Hu Q; Liang X; Chen D; Li B; Tang J; Zhang JH
    Exp Neurol; 2015 Mar; 265():22-9. PubMed ID: 25542160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A broad-spectrum matrix metalloproteinase inhibitor prevents hemorrhagic complications induced by tissue plasminogen activator in mice.
    Mishiro K; Ishiguro M; Suzuki Y; Tsuruma K; Shimazawa M; Hara H
    Neuroscience; 2012 Mar; 205():39-48. PubMed ID: 22244977
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
    Ishiguro M; Kawasaki K; Suzuki Y; Ishizuka F; Mishiro K; Egashira Y; Ikegaki I; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
    Neuroscience; 2012 Sep; 220():302-12. PubMed ID: 22710066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploring Contraindications for Thrombolysis: Risk of Hemorrhagic Transformation and Neurological Deterioration after Thrombolysis in Mice with Recent Ischemic Stroke and Hyperglycemia.
    Gelhard S; Kestner RI; Armbrust M; Steinmetz H; Foerch C; Bohmann FO
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of superoxide dismutase in hyperglycemic focal cerebral ischemia in the rat.
    Bémeur C; Ste-Marie L; Desjardins P; Butterworth RF; Vachon L; Montgomery J; Hazell AS
    Neurochem Int; 2004 Dec; 45(8):1167-74. PubMed ID: 15380626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperglycemia and hemorrhagic transformation of cerebral infarcts.
    Broderick JP; Hagen T; Brott T; Tomsick T
    Stroke; 1995 Mar; 26(3):484-7. PubMed ID: 7886729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
    Pfefferkorn T; Rosenberg GA
    Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.
    Cai Y; Liu X; Chen W; Wang Z; Xu G; Zeng Y; Ma Y
    Exp Neurol; 2015 Apr; 266():120-6. PubMed ID: 25708985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations in the gut microbiome with hemorrhagic transformation in experimental stroke.
    Huang Q; Di L; Yu F; Feng X; Liu Z; Wei M; Luo Y; Xia J
    CNS Neurosci Ther; 2022 Jan; 28(1):77-91. PubMed ID: 34591349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential early mitogen-activated protein kinase activation in hyperglycemic ischemic brain injury in the rat.
    Farrokhnia N; Roos MW; Terént A; Lennmyr F
    Eur J Clin Invest; 2005 Jul; 35(7):457-63. PubMed ID: 16008548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke.
    Castellanos M; Leira R; Serena J; Pumar JM; Lizasoain I; Castillo J; Dávalos A
    Stroke; 2003 Jan; 34(1):40-6. PubMed ID: 12511748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.
    Copin JC; Gasche Y
    Brain Res; 2008 Dec; 1243():161-6. PubMed ID: 18835259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased risk of hemorrhagic transformation in ischemic stroke occurring during warfarin anticoagulation: an experimental study in mice.
    Pfeilschifter W; Spitzer D; Czech-Zechmeister B; Steinmetz H; Foerch C
    Stroke; 2011 Apr; 42(4):1116-21. PubMed ID: 21330626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroprotective effect of acute ethanol administration in a rat with transient cerebral ischemia.
    Wang F; Wang Y; Geng X; Asmaro K; Peng C; Sullivan JM; Ding JY; Ji X; Ding Y
    Stroke; 2012 Jan; 43(1):205-10. PubMed ID: 22052512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.
    Montaner J; Fernández-Cadenas I; Molina CA; Monasterio J; Arenillas JF; Ribó M; Quintana M; Chacón P; Andreu AL; Alvarez-Sabín J
    Stroke; 2003 Dec; 34(12):2851-5. PubMed ID: 14605329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke.
    Rosell A; Alvarez-Sabín J; Arenillas JF; Rovira A; Delgado P; Fernández-Cadenas I; Penalba A; Molina CA; Montaner J
    Stroke; 2005 Jul; 36(7):1415-20. PubMed ID: 15947272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.